You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Patient Simulations in Personalized Planning for Prostate Cancer

  • Authors: Himisha Beltran, MD; Daniel Saltzstein, MD
  • CME / ABIM MOC Released: 3/24/2022
  • Valid for credit through: 3/24/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of hematology/oncology specialists and urologists.

The goal of this activity is to evaluate the performance of oncologists and urologists in personalizing prostate cancer treatments based on disease status, comorbidities, drug-drug interactions, or potential adverse events.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Analyzing test results to appropriately categorize patients with prostate cancer (PC)
    • Prescribing the most appropriate therapy for PC based on patient comorbidities and disease status
    • Selecting the optimal therapy for a patient with PC reflective of drug-drug interactions
    • Monitoring for adverse events of selected PC therapy


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Himisha Beltran, MD

    Associate Professor of Medicine
    Department of Medical Oncology
    Dana Farber Cancer Institute
    Harvard Medical School
    Boston, Massachusetts


    Himisha Beltran, MD, has disclosed the following relevant financial relationships:
    Grants for clinical research from: Bristol Myers Squibb; Janssen
    Advisor or consultant for: Amgen Inc.; AstraZeneca; Blue Earth Diagnostics; Foundation Medicine; Janssen; Merck & Co., Inc.; Oncorus; Pfizer

  • Daniel Saltzstein, MD

    Medical Director of Research and
    Director of the Advanced Therapeutics Clinic
    Urology San Antonio
    San Antonio, Texas


    Daniel Saltzstein, MD, has disclosed the following relevant financial relationships:
    Independent contract for: Specialty Networks
    Grants for clinical research from: Bayer; Janssen; Myovant
    Advisor or consultant for: Astellas; Bayer; Janssen; Myovant
    Speaker or member of speakers bureau for: Bayer; Janssen; Myovant


  • Stephanie Baumhover, PharmD, BCPS

    Medical Education Director, MedSims


    Disclosure: Stephanie Baumhover, PharmD, BCPS, has disclosed no relevant financial relationships.

  • Terra Sumstine

    Chichester Associates Inc, Phoenix, Arizona


    Disclosure: Terra Sumstine has disclosed no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Patient Simulations in Personalized Planning for Prostate Cancer

Authors: Himisha Beltran, MD; Daniel Saltzstein, MDFaculty and Disclosures

CME / ABIM MOC Released: 3/24/2022

Valid for credit through: 3/24/2023, 11:59 PM EST



What is new in the treatment of prostate cancer?
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

patient simulation
  • Print